StockNews.com assumed coverage on shares of Aspira Women’s Health (NASDAQ:AWH – Free Report) in a research report released on Monday morning. The firm issued a hold rating on the stock.
Separately, Alliance Global Partners reduced their price target on shares of Aspira Women’s Health from $7.00 to $5.50 and set a “buy” rating on the stock in a research report on Wednesday, August 14th.
Aspira Women’s Health Stock Performance
Hedge Funds Weigh In On Aspira Women’s Health
An institutional investor recently bought a new position in Aspira Women’s Health stock. Pine Valley Investments Ltd Liability Co purchased a new position in Aspira Women’s Health Inc. (NASDAQ:AWH – Free Report) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 31,200 shares of the company’s stock, valued at approximately $25,000. Pine Valley Investments Ltd Liability Co owned approximately 0.19% of Aspira Women’s Health at the end of the most recent reporting period. 12.19% of the stock is owned by institutional investors and hedge funds.
Aspira Women’s Health Company Profile
Aspira Women's Health Inc, together with its subsidiaries, discovers, develops, and commercializes of noninvasive AI-powered diagnostic tests for gynecologic diseases in the United States. The company's products include Ova1Plus, a qualitative serum test to assess the likelihood of malignancy in women with an ovarian adnexal mass; Overa, a biomarker test intended to maintain Ova1's high sensitivity; and OvaWatch, a laboratory developed tests to assist in the initial clinical assessment of malignancy risk in all women thought to have an indeterminate or benign adnexal mass.
Featured Articles
- Five stocks we like better than Aspira Women’s Health
- What is a Special Dividend?
- Abacus Life’s CEO on Cracking the Code of Longevity Returns
- How to Capture the Benefits of Dividend Increases
- Elon Musk and Trump Push for Self-Driving Cars: 3 Stocks to Gain
- How to Buy Cheap Stocks Step by Step
- Discover the 3 Best Performing Stocks That Went Public in 2024
Receive News & Ratings for Aspira Women's Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspira Women's Health and related companies with MarketBeat.com's FREE daily email newsletter.